Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 1876 AL 1890

Effects of MAO‑B inhibitors in life quality of Parkinson's disease patients: A systematic review and meta‑analysis

Liu X, Su J, Zhang J, Li Z, Huang K, Lin D, Tao E.

Behav Brain Res. 2025 Mar 5;480:115410. doi: 10.1016/j.bbr.2024.115410. Epub 2024 Dec 26.

Terminology controversies

Jack CR Jr.

Alzheimers Dement. 2025 Feb;21(2):e14466. doi: 10.1002/alz.14466. Epub 2024 Dec 28.

Alexithymia in Parkinson's Disease: A Meta-analysis

Fernández-Fernández R, Ibias J, Del Toro-Pérez C, Lahera G, Gasca-Salas C.

Am J Geriatr Psychiatry. 2025 Jun;33(6):638-653. doi: 10.1016/j.jagp.2024.11.009. Epub 2024 Dec 2.

Duration of "Good On" time per dose: Immediate-release carbidopa-levodopa vs. extended-release carbidopa-levodopa (IPX203, CREXONT®)

Hauser RA, Fernandez HH, Jimenez-Shahed J, Allard S, Banisadr G, Fisher S, D'Souza R.

Parkinsonism Relat Disord. 2025 Feb;131:107239. doi: 10.1016/j.parkreldis.2024.107239. Epub 2024 Dec 15.

Effectiveness of non-invasive vagal nerve stimulation in Parkinson's disease: A comprehensive systematic review and meta-analysis

Abouelmagd ME, Yousef O, Ibrahim IA, Elshahat A.

J Clin Neurosci. 2025 Mar;133:111016. doi: 10.1016/j.jocn.2024.111016. Epub 2024 Dec 28.

Gut-brain axis and brain health: modulating neuroinflammation, cognitive decline, and neurodegeneration

Trisal A, Singh I, Garg G, Jorwal K, Singh AK.

3 Biotech. 2025 Jan;15(1):25. doi: 10.1007/s13205-024-04187-0. Epub 2024 Dec 27.

Statins as potential disease-modifying therapy of Parkinson's disease: a systematic review and meta-analysis with trial sequential analysis

Gonçalves OR, Nascimento AB, Soares VG, Abraham D, de Almeida Monteiro G, Freitas JLR, da Cunha Monteiro Ribeiro JP, Ribeiro BL, de Oliveira JVA, Dos Santos MAR, Telles JPM, Sekeff-Sallem F, Almeida KJ.

Acta Neurol Belg. 2025 Aug;125(4):915-922. doi: 10.1007/s13760-024-02709-4. Epub 2024 Dec 30.

Determination of High-Sensitivity C-reactive protein in Patient with Early Parkinson's disease

Emran MM, Malik SS, Wahiduzzaman M, Paul GK, Fatema N.

Mymensingh Med J. 2025 Jan;34(1):159-165.

Indoles as promising Therapeutics: A review of recent drug discovery efforts

Pravin NJ, Kavalapure RS, Alegaon SG, Gharge S, Ranade SD.

Bioorg Chem. 2025 Jan;154:108092. doi: 10.1016/j.bioorg.2024.108092. Epub 2024 Dec 24.

Advances in Parkinson's Disease Diagnosis Through Diffusion Kurtosis Imaging and Radiomics

Nada A.

Acad Radiol. 2025 Feb;32(2):930-931. doi: 10.1016/j.acra.2024.12.048. Epub 2024 Dec 30.

Neuroprotective Agents: Implications for Parkinson's Disease Treatment

Algantri KR, Mohamed W, Nasir MHM, Nahas ARMF.

Curr Alzheimer Res. 2025;22(9):634-660. doi: 10.2174/0115672050368080250529075006.

Genetically Engineered Mouse Models for Alzheimer Disease and Frontotemporal Dementia: New Insights from Single-Cell and Spatial Transcriptomics

Chiu Y, Xia S, Qiao H, Zhao Z.

Am J Pathol. 2025 Nov;195(11):2118-2130. doi: 10.1016/j.ajpath.2024.11.006. Epub 2024 Dec 19.

Stem Cell Revolutions: An alliance for Parkinson's disease driven by European Commission consortia

Cattaneo E, Besusso D.

Pharmacol Res. 2025 Feb;212:107569. doi: 10.1016/j.phrs.2024.107569. Epub 2024 Dec 31.

Advance Care Planning Billing Codes Associated With Decreased Healthcare Utilization in Neurological Disease

Brown G, Jesus S, Leboffe E, Esch A, Newport K.

J Healthc Manag. 2025 Jan-Feb 01;70(1):58-73. doi: 10.1097/JHM-D-23-00234. Epub 2024 Dec 31.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias